HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.

Abstract
The insulinoma-associated protein 2 (IA-2) is a phosphatase-like autoantigen inducing T and B cell responses associated with human insulin-dependent diabetes mellitus (IDDM). We now report that T cell responses to IA-2 can also be detected in the nonobese diabetic (NOD) mouse, a model of human IDDM. Cytokine secretion in response to purified mouse rIA-2, characterized by high IFN-gamma and relatively low IL-10 and IL-6 secretion, was elicited in spleen cells from unprimed NOD mice. Conversely, no response to IA-2 was induced in spleen cells from BALB/c, C57BL/6, or Biozzi AB/H mice that express, like NOD, the I-A(g7) class II molecule, but are not susceptible to spontaneous IDDM. The IA-2-induced IFN-gamma response in NOD spleen cells could already be detected at 3 wk and peaked at 8 wk of age, whereas the IL-10 secretion was maximal at 4 wk of age and then waned. IA-2-dependent IFN-gamma secretion was induced in CD4(+) cells from spleen as well as pancreatic and mesenteric lymph nodes. It required Ag presentation by I-A(g7) molecules and engagement of the CD4 coreceptor. Interestingly, cytokines were produced in the absence of cell proliferation and IL-2 secretion. The biological relevance of the response to IA-2 is indicated by the enhanced IDDM following a single injection of the recombinant protein emulsified in IFA into 18-day-old NOD mice. In addition, IFN-gamma production in response to IA-2 and IDDM acceleration could be induced by IL-12 administration to 12-day-old NOD mice. These results identify IA-2 as an early T cell-inducing autoantigen in the NOD mouse and indicate a role for the IA-2-induced Th1 cell response in IDDM pathogenesis.
AuthorsS Trembleau, G Penna, S Gregori, G Magistrelli, A Isacchi, L Adorini
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 165 Issue 12 Pg. 6748-55 (Dec 15 2000) ISSN: 0022-1767 [Print] United States
PMID11120794 (Publication Type: Journal Article)
Chemical References
  • Autoantigens
  • Cytokines
  • Epitopes
  • Histocompatibility Antigens Class II
  • I-A g7 antigen
  • Isoenzymes
  • Membrane Proteins
  • Recombinant Proteins
  • Interleukin-12
  • Interferon-gamma
  • PTPRN protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases
  • Ptprn protein, mouse
  • Receptor-Like Protein Tyrosine Phosphatases, Class 8
  • Glutamate Decarboxylase
  • glutamate decarboxylase 2
Topics
  • Aging (immunology)
  • Animals
  • Antigen Presentation
  • Autoantigens (administration & dosage, immunology)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Cells, Cultured
  • Cytokines (biosynthesis)
  • Diabetes Mellitus, Type 1 (etiology, immunology)
  • Drug Administration Schedule
  • Epitopes (immunology)
  • Female
  • Glutamate Decarboxylase (administration & dosage, immunology)
  • Histocompatibility Antigens Class II (immunology, metabolism)
  • Immunization
  • Injections, Intraperitoneal
  • Injections, Subcutaneous
  • Interferon-gamma (metabolism)
  • Interleukin-12 (administration & dosage)
  • Islets of Langerhans (immunology)
  • Isoenzymes (administration & dosage, immunology)
  • Lymph Nodes (cytology, immunology, metabolism)
  • Male
  • Membrane Proteins (administration & dosage, genetics, immunology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases (administration & dosage, genetics, immunology)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 8
  • Recombinant Proteins (administration & dosage, immunology)
  • Spleen (cytology, immunology, metabolism)
  • Th1 Cells (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: